Boston Scientific Corp.

EMR Device treats diseases of upper GI tract.
Health, Medical, & Dental Supplies and Equipment

EMR Device treats diseases of upper GI tract.

MARLBOROUGH, Mass., – Boston Scientific Corporation (NYSE: BSX) announced today the launch of the Captivator™ EMR Device for Endoscopic Mucosal Resection (EMR), a minimally invasive alternative to an esophagectomy, a surgical procedure that  removes part of the esophagus in upper gastrointestinal (GI) tract cases. EMR enables staging and removal of precancerous tissue and early esophageal...

Read More »
EMR Device treats diseases of upper GI tract.
Health, Medical, & Dental Supplies and Equipment

EMR Device treats diseases of upper GI tract.

MARLBOROUGH, Mass.,- – Boston Scientific Corporation (NYSE: BSX) announced today the launch of the Captivator™ EMR Device for Endoscopic Mucosal Resection (EMR), a minimally invasive alternative to an esophagectomy, a surgical procedure that  removes part of the esophagus in upper gastrointestinal (GI) tract cases. EMR enables staging and removal of precancerous tissue and early...

Read More »
Health, Medical, & Dental Supplies and Equipment

Boston Scientific Announces CE Mark for MRI Compatible Labeling for ICD and CRT-D Systems

Updated labeling allows backwards-compatibility for MRI scans for the industry's longest-lasting ICD and CRT-D systems MARLBOUROUGH, Mass.,- – Boston Scientific Corporation (NYSE: BSX) has received CE Mark on magnetic resonance imaging (MRI) conditional labeling for the current family of EL (Extended Longevity) and MINI implantable cardioverter defibrillator (ICD) and the X4 cardiac...

Read More »
Health, Medical, & Dental Supplies and Equipment

Boston Scientific Announces CE Mark for MRI Compatible Labeling for ICD and CRT-D Systems

Updated labeling allows backwards-compatibility for MRI scans for the industry's longest-lasting ICD and CRT-D systems MARLBOUROUGH, Mass.,Â- – Boston Scientific Corporation (NYSE: BSX) has received CE Mark on magnetic resonance imaging (MRI) conditional labeling for the current family of EL (Extended Longevity) and MINI implantable cardioverter defibrillator (ICD) and the X4 cardiac...

Read More »
Chemicals & Gases

Boston Scientific Announces Strategic Collaboration with Brainlab AG

MARLBOROUGH, Mass. –- Boston Scientific Corporation (NYSE: BSX) announces a collaboration with Brainlab AG, a leading software-driven medical technology company that helps improve patient treatment planning and surgical navigation. The collaboration provides patients and physicians a comprehensive portfolio for Deep Brain Stimulation (DBS) therapy. DBS is intended to treat a variety of...

Read More »
Chemicals & Gases

Boston Scientific Announces Strategic Collaboration with Brainlab AG

MARLBOROUGH, Mass. –Â- Boston Scientific Corporation (NYSE: BSX) announces a collaboration with Brainlab AG, a leading software-driven medical technology company that helps improve patient treatment planning and surgical navigation. The collaboration provides patients and physicians a comprehensive portfolio for Deep Brain Stimulation (DBS) therapy. DBS is intended to treat a variety of...

Read More »
Fluid & Gas Flow Equipment

Visualization System supports pancreatoscopy procedures.

Used for cholangioscopy and pancreatoscopy procedures, SpyGlass DS Direct Visualization System enables advanced diagnosis and treatment of pancreatico-biliary diseases. System consists of SpyScope™ DS Access and Delivery Catheter, and single-use scope to eliminate probe reprocessing and image degradation over multiple uses. Integrated digital sensor provides wide field of view and optimal...

Read More »
Fluid & Gas Flow Equipment

Visualization System supports pancreatoscopy procedures.

Used for cholangioscopy and pancreatoscopy procedures, SpyGlass DS Direct Visualization System enables advanced diagnosis and treatment of pancreatico-biliary diseases. System consists of SpyScope™ DS Access and Delivery Catheter, and single-use scope to eliminate probe reprocessing and image degradation over multiple uses. Integrated digital sensor provides wide field of view and optimal...

Read More »
Electrical Equipment & Systems

Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs

Companies Reach Agreement to Develop a New and Differentiated FFR Guidewire and Next Generation Boston Scientific Rotablator(TM) RotaWire(TM) MARLBOROUGH, Mass. and NAGOYA, Japan, -- Boston Scientific Corporation (NYSE: BSX) and ASAHI INTECC (Securities Code 7747, Second Section, Tokyo and Nagoya Stock Exchange) have formalized plans to develop a new, differentiated fractional flow reserve (FFR)...

Read More »
Health, Medical, & Dental Supplies and Equipment

Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs

Companies Reach Agreement to Develop a New and Differentiated FFR Guidewire and Next Generation Boston Scientific Rotablator(TM) RotaWire(TM) MARLBOROUGH, Mass. and NAGOYA, Japan, -- Boston Scientific Corporation (NYSE: BSX) and ASAHI INTECC (Securities Code 7747, Second Section, Tokyo and Nagoya Stock Exchange) have formalized plans to develop a new, differentiated fractional flow reserve (FFR)...

Read More »
Mergers & Acquisitions

Boston Scientific Announces Acquisition of The LumenR™ Tissue Retractor System

Technology to Improve Management of Gastrointestinal Diseases MARLBOROUGH, Mass., Nov. 3, 2016 - Boston Scientific (NYSE: BSX) today announced the acquisition of the LumenR™ Tissue Retractor System from LumenR LLC, a privately held Newark, California based company. The LumenR Tissue Retractor System is currently in development for use during endoscopic resection of lesions in the colon,...

Read More »
Mergers & Acquisitions

Boston Scientific Announces Acquisition of The LumenR™ Tissue Retractor System

Technology to Improve Management of Gastrointestinal Diseases MARLBOROUGH, Mass., Nov. 3, 2016 - Boston Scientific (NYSE: BSX) today announced the acquisition of the LumenR™ Tissue Retractor System from LumenR LLC, a privately held Newark, California based company. The LumenR Tissue Retractor System is currently in development for use during endoscopic resection of lesions in the colon,...

Read More »
Mergers & Acquisitions

Boston Scientific Announces Additional Investment and Right to Acquire MValve Technologies

Investment continues alliance for percutaneous mitral valve replacement established in 2012 MARLBOROUGH, Mass. and HERZLIYA, Israel - Boston Scientific Corporation (NYSE: BSX) today announced that it has closed on an additional round of financing with MValve Technologies Ltd., a developer of a percutaneous mitral valve replacement system, designed to work with the Boston Scientific LOTUS™...

Read More »
Mergers & Acquisitions

Boston Scientific Announces Additional Investment and Right to Acquire MValve Technologies

Investment continues alliance for percutaneous mitral valve replacement established in 2012 MARLBOROUGH, Mass. and HERZLIYA, Israel - Boston Scientific Corporation (NYSE: BSX) today announced that it has closed on an additional round of financing with MValve Technologies Ltd., a developer of a percutaneous mitral valve replacement system, designed to work with the Boston Scientific LOTUS™...

Read More »
EMR Device treats diseases of upper GI tract.
Health, Medical, & Dental Supplies and Equipment

EMR Device treats diseases of upper GI tract.

MARLBOROUGH, Mass., – Boston Scientific Corporation (NYSE: BSX) announced today the launch of the Captivator™ EMR Device for Endoscopic Mucosal Resection (EMR), a minimally invasive alternative to an esophagectomy, a surgical procedure that  removes part of the esophagus in upper gastrointestinal (GI) tract cases. EMR enables staging and removal of precancerous tissue and early esophageal...

Read More »
EMR Device treats diseases of upper GI tract.
Health, Medical, & Dental Supplies and Equipment

EMR Device treats diseases of upper GI tract.

MARLBOROUGH, Mass.,- – Boston Scientific Corporation (NYSE: BSX) announced today the launch of the Captivator™ EMR Device for Endoscopic Mucosal Resection (EMR), a minimally invasive alternative to an esophagectomy, a surgical procedure that  removes part of the esophagus in upper gastrointestinal (GI) tract cases. EMR enables staging and removal of precancerous tissue and early...

Read More »
Health, Medical, & Dental Supplies and Equipment

Boston Scientific Announces CE Mark for MRI Compatible Labeling for ICD and CRT-D Systems

Updated labeling allows backwards-compatibility for MRI scans for the industry's longest-lasting ICD and CRT-D systems MARLBOUROUGH, Mass.,- – Boston Scientific Corporation (NYSE: BSX) has received CE Mark on magnetic resonance imaging (MRI) conditional labeling for the current family of EL (Extended Longevity) and MINI implantable cardioverter defibrillator (ICD) and the X4 cardiac...

Read More »
Health, Medical, & Dental Supplies and Equipment

Boston Scientific Announces CE Mark for MRI Compatible Labeling for ICD and CRT-D Systems

Updated labeling allows backwards-compatibility for MRI scans for the industry's longest-lasting ICD and CRT-D systems MARLBOUROUGH, Mass.,Â- – Boston Scientific Corporation (NYSE: BSX) has received CE Mark on magnetic resonance imaging (MRI) conditional labeling for the current family of EL (Extended Longevity) and MINI implantable cardioverter defibrillator (ICD) and the X4 cardiac...

Read More »
Mergers & Acquisitions

Boston Scientific Closes Acquisition of the American Medical Systems Male Urology Portfolio

MARLBOROUGH, Mass. - Boston Scientific Corporation (NYSE: BSX) has closed on the previously announced agreement with Endo International plc (NASDAQ: ENDP) (TSX: ENL) to purchase American Medical Systems' (AMS) Men's Health and Prostate Health businesses, for $1.6 billion in up-front cash and a potential additional $50 million milestone based on 2016 sales. The acquisition positions Boston...

Read More »
Mergers & Acquisitions

Boston Scientific Closes Acquisition of the American Medical Systems Male Urology Portfolio

MARLBOROUGH, Mass. - Boston Scientific Corporation (NYSE: BSX) has closed on the previously announced agreement with Endo International plc (NASDAQ: ENDP) (TSX: ENL) to purchase American Medical Systems' (AMS) Men's Health and Prostate Health businesses, for $1.6 billion in up-front cash and a potential additional $50 million milestone based on 2016 sales. The acquisition positions Boston...

Read More »

All Topics